Coronavirus Latest News

Omicron: China’s Sinovac says third shot could help fight variant, as Hong Kong study fails to reveal antibodies with two

The Covid-19 vaccine by Sinovac Biotech is not able to produce adequate antibodies to neutralise the highly mutated coronavirus strain Omicron, according to new research from the University of Hong Kong.Both the Sinovac vaccine and another by Pfizer-BioNTech produced “inadequate” antibody responses to the variant, HKU scientists said in a statement on Tuesday night, calling for the use of boosters to potentially enhance protection.Beijing-based Sinovac on Wednesday responded with a statement…

Read the original article at South China Morning Post

Related Articles

Back to top button